<?xml version="1.0" encoding="UTF-8"?><!-- Normalized for easier text mining. --><xocs:doc xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://schema.elsevier.com/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>276216</xocs:cid><xocs:srctitle>Stem Cell Research</xocs:srctitle><xocs:normalized-srctitle>STEMCELLRESEARCH</xocs:normalized-srctitle><xocs:orig-load-date>2013-08-09</xocs:orig-load-date><xocs:ew-transaction-id>2014-02-05T12:46:40</xocs:ew-transaction-id><xocs:eid>1-s2.0-S1873506113001116</xocs:eid><xocs:pii-formatted>S1873-5061(13)00111-6</xocs:pii-formatted><xocs:pii-unformatted>S1873506113001116</xocs:pii-unformatted><xocs:doi>10.1016/j.scr.2013.07.011</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.1</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S1873506113X00054</xocs:hub-eid><xocs:timestamp>2014-02-05T10:34:15.92862-05:00</xocs:timestamp><xocs:issns><xocs:issn-primary-formatted>1873-5061</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>18735061</xocs:issn-primary-unformatted></xocs:issns><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NONE</xocs:funding-body-id><xocs:crossmark>false</xocs:crossmark><xocs:vol-first>11</xocs:vol-first><xocs:iss-first>3</xocs:iss-first><xocs:vol-iss-suppl-text>Volume 11, Issue 3</xocs:vol-iss-suppl-text><xocs:sort-order>14</xocs:sort-order><xocs:first-fp>1103</xocs:first-fp><xocs:last-lp>1116</xocs:last-lp><xocs:pages><xocs:first-page>1103</xocs:first-page><xocs:last-page>1116</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>201311</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>November 2013</xocs:cover-date-text><xocs:cover-date-start>2013-11-01</xocs:cover-date-start><xocs:cover-date-end>2013-11-30</xocs:cover-date-end><xocs:cover-date-year>2013</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Regular Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2013 Published by Elsevier B.V.</xocs:copyright-line><xocs:normalized-article-title>SCALABLEEXPANSIONHUMANINDUCEDPLURIPOTENTSTEMCELLSINDEFINEDXENOFREEE8MEDIUMUNDERADHERENTSUSPENSIONCULTURECONDITIONS</xocs:normalized-article-title><xocs:normalized-first-auth-surname>WANG</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>Y</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Materials and methods</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Maintenance of hiPSCs in adhesion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Suspension culture of hiPSCs</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Analysis for aggregates and metabolism</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Flow cytometry</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Immunofluorescent staining of hiPSCs in adhesion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Immunofluorescent staining of cell aggregates in suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Karyotyping</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>In vitro hematopoietic differentiation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>In vitro spontaneous differentiation of germ cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Teratoma formation assay</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cryopreservation and recovery of hiPSCs in suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Computational fluid dynamics (CFD) analysis</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Data presentation and statistics</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Adaptation and robust growth in feeder-free adhesion culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Serial passaging and expansion in static suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Initiation of dynamic suspension culture of hiPSCs</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Computational fluid dynamics (CFD) analysis of glass-ball spinner flask</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Optimization of agitating speed and cell split interval</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Characterization of hiPSCs in dynamic suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Serial passaging and expansion of hiPSCs in suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Differentiation potential of hiPSCs in suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cryopreservation and recovery of hiPSCs in suspension culture</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Author contributions</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Competing financial interests</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:acknowledgment"><xocs:item-toc-section-title>Acknowledgment</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-label>Appendix A</xocs:item-toc-label><xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:bibliography"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid="rf0190"><xocs:ref-normalized-surname>ABACI</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>97</xocs:ref-first-fp><xocs:ref-last-lp>105</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0085"><xocs:ref-normalized-surname>ABBASALIZADEH</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>831</xocs:ref-first-fp><xocs:ref-last-lp>851</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0155"><xocs:ref-normalized-surname>ADAMO</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>1131-U120</xocs:ref-first-fp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0070"><xocs:ref-normalized-surname>AMIT</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>572</xocs:ref-first-fp><xocs:ref-last-lp>579</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0195"><xocs:ref-normalized-surname>BEERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>2029</xocs:ref-first-fp><xocs:ref-last-lp>2040</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0120"><xocs:ref-normalized-surname>BIGDELI</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>146</xocs:ref-first-fp><xocs:ref-last-lp>153</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0200"><xocs:ref-normalized-surname>BILGEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>282</xocs:ref-first-fp><xocs:ref-last-lp>294</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0040"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>424-U76</xocs:ref-first-fp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0090"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>388</xocs:ref-first-fp><xocs:ref-last-lp>402</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0005"><xocs:ref-normalized-surname>CHOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>518</xocs:ref-first-fp><xocs:ref-last-lp>529</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0205"><xocs:ref-normalized-surname>COLLIGNON</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>5929</xocs:ref-first-fp><xocs:ref-last-lp>5941</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0180"><xocs:ref-normalized-surname>CORMIER</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>3233</xocs:ref-first-fp><xocs:ref-last-lp>3245</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0125"><xocs:ref-normalized-surname>DESBORDES</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>111</xocs:ref-first-fp><xocs:ref-last-lp>130</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0010"><xocs:ref-normalized-surname>DOWEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>2013</xocs:ref-first-fp><xocs:ref-last-lp>2021</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0095"><xocs:ref-normalized-surname>FLURI</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>509</xocs:ref-first-fp><xocs:ref-last-lp>516</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0225"><xocs:ref-normalized-surname>HOEBEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>549</xocs:ref-first-fp><xocs:ref-last-lp>580</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0025"><xocs:ref-normalized-surname>KEHOE</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>405</xocs:ref-first-fp><xocs:ref-last-lp>421</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0100"><xocs:ref-normalized-surname>KRAWETZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>573</xocs:ref-first-fp><xocs:ref-last-lp>582</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0045"><xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>688</xocs:ref-first-fp><xocs:ref-last-lp>698</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0185"><xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>580</xocs:ref-first-fp><xocs:ref-last-lp>589</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0050"><xocs:ref-normalized-surname>LUDWIG</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>185</xocs:ref-first-fp><xocs:ref-last-lp>187</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0020"><xocs:ref-normalized-surname>MEHTA</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>1434</xocs:ref-first-fp><xocs:ref-last-lp>1441</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0140"><xocs:ref-normalized-surname>NG</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>1601</xocs:ref-first-fp><xocs:ref-last-lp>1603</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0135"><xocs:ref-normalized-surname>NG</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>768</xocs:ref-first-fp><xocs:ref-last-lp>776</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0230"><xocs:ref-normalized-surname>NIEBRUEGGE</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>493</xocs:ref-first-fp><xocs:ref-last-lp>507</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0170"><xocs:ref-normalized-surname>OCONNOR</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>323</xocs:ref-first-fp><xocs:ref-last-lp>328</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0030"><xocs:ref-normalized-surname>OKITA</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>313-U1</xocs:ref-first-fp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0075"><xocs:ref-normalized-surname>OLMER</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>51</xocs:ref-first-fp><xocs:ref-last-lp>64</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0105"><xocs:ref-normalized-surname>OLMER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>772</xocs:ref-first-fp><xocs:ref-last-lp>784</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0210"><xocs:ref-normalized-surname>PAPOUTSAKIS</xocs:ref-normalized-surname><xocs:ref-pub-year>1991</xocs:ref-pub-year><xocs:ref-first-fp>427</xocs:ref-first-fp><xocs:ref-last-lp>437</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0110"><xocs:ref-normalized-surname>SINGH</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>165</xocs:ref-first-fp><xocs:ref-last-lp>179</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0115"><xocs:ref-normalized-surname>STEINER</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>361</xocs:ref-first-fp><xocs:ref-last-lp>364</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0130"><xocs:ref-normalized-surname>STOVER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>137</xocs:ref-first-fp><xocs:ref-last-lp>146</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0175"><xocs:ref-normalized-surname>SUCOSKY</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>34</xocs:ref-first-fp><xocs:ref-last-lp>46</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0055"><xocs:ref-normalized-surname>VALLIER</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>4495</xocs:ref-first-fp><xocs:ref-last-lp>4509</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0215"><xocs:ref-normalized-surname>VENKAT</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>456</xocs:ref-first-fp><xocs:ref-last-lp>466</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0060"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>4111</xocs:ref-first-fp><xocs:ref-last-lp>4119</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0065"><xocs:ref-normalized-surname>WATANABE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>681</xocs:ref-first-fp><xocs:ref-last-lp>686</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0160"><xocs:ref-normalized-surname>YAMAMOTO</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>H1915</xocs:ref-first-fp><xocs:ref-last-lp>H1924</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0015"><xocs:ref-normalized-surname>YE</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>5473</xocs:ref-first-fp><xocs:ref-last-lp>5480</xocs:ref-last-lp><xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0165"><xocs:ref-normalized-surname>YIRME</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>1227</xocs:ref-first-fp><xocs:ref-last-lp>1241</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0220"><xocs:ref-normalized-surname>YOUN</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>801</xocs:ref-first-fp><xocs:ref-last-lp>810</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0035"><xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>1917</xocs:ref-first-fp><xocs:ref-last-lp>1920</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0145"><xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>461</xocs:ref-first-fp><xocs:ref-last-lp>471</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0150"><xocs:ref-normalized-surname>ZHAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>163</xocs:ref-first-fp><xocs:ref-last-lp>171</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="rf0080"><xocs:ref-normalized-surname>ZWEIGERDT</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>689</xocs:ref-first-fp><xocs:ref-last-lp>700</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S1873-5061(13)00111-6</xocs:pii-formatted><xocs:pii-unformatted>S1873506113001116</xocs:pii-unformatted><xocs:eid>1-s2.0-S1873506113001116</xocs:eid><xocs:doi>10.1016/j.scr.2013.07.011</xocs:doi><xocs:cid>276216</xocs:cid><xocs:timestamp>2014-02-05T10:34:15.92862-05:00</xocs:timestamp><xocs:path>/276216/1-s2.0-S1873506113X00054/1-s2.0-S1873506113001116/</xocs:path><xocs:cover-date-start>2013-11-01</xocs:cover-date-start><xocs:cover-date-end>2013-11-30</xocs:cover-date-end><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NONE</xocs:funding-body-id><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S1873506113001116-main.pdf</xocs:attachment-eid><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>3049390</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>14</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S1873506113001116-main_1.png</xocs:attachment-eid><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>131501</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr7_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>249250</xocs:filesize><xocs:pixel-height>1057</xocs:pixel-height><xocs:pixel-width>2014</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr6_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>1080520</xocs:filesize><xocs:pixel-height>2888</xocs:pixel-height><xocs:pixel-width>2628</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr5_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>1715274</xocs:filesize><xocs:pixel-height>2411</xocs:pixel-height><xocs:pixel-width>2014</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr4_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>414753</xocs:filesize><xocs:pixel-height>1709</xocs:pixel-height><xocs:pixel-width>2736</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr3_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>918956</xocs:filesize><xocs:pixel-height>3593</xocs:pixel-height><xocs:pixel-width>2766</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr2_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>918307</xocs:filesize><xocs:pixel-height>2358</xocs:pixel-height><xocs:pixel-width>2014</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr1_lrg.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>422390</xocs:filesize><xocs:pixel-height>1127</xocs:pixel-height><xocs:pixel-width>1896</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr7.jpg</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>54052</xocs:filesize><xocs:pixel-height>398</xocs:pixel-height><xocs:pixel-width>758</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr6.jpg</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>114491</xocs:filesize><xocs:pixel-height>652</xocs:pixel-height><xocs:pixel-width>593</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr5.jpg</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>290676</xocs:filesize><xocs:pixel-height>907</xocs:pixel-height><xocs:pixel-width>758</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr4.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>61921</xocs:filesize><xocs:pixel-height>386</xocs:pixel-height><xocs:pixel-width>618</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr3.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>122832</xocs:filesize><xocs:pixel-height>812</xocs:pixel-height><xocs:pixel-width>625</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr2.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>200060</xocs:filesize><xocs:pixel-height>887</xocs:pixel-height><xocs:pixel-width>758</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr1.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>87757</xocs:filesize><xocs:pixel-height>424</xocs:pixel-height><xocs:pixel-width>714</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr7.sml</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6765</xocs:filesize><xocs:pixel-height>115</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr6.sml</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6088</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>149</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr5.sml</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10743</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>137</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr4.sml</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5464</xocs:filesize><xocs:pixel-height>137</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr3.sml</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5991</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>126</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr2.sml</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8980</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>140</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-gr1.sml</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6739</xocs:filesize><xocs:pixel-height>130</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S1873506113001116-mmc1.pdf</xocs:attachment-eid><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>5959373</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc><xocs:refkeys><xocs:refkey3>WANGX2013X1103</xocs:refkey3><xocs:refkey4lp>WANGX2013X1103X1116</xocs:refkey4lp><xocs:refkey4ai>WANGX2013X1103XY</xocs:refkey4ai><xocs:refkey5>WANGX2013X1103X1116XY</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-08-12T08:58:34Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>Author</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://creativecommons.org/licenses/by/3.0/</xocs:oa-user-license></xocs:open-access></xocs:meta><xocs:serial-item><article xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" version="5.2" docsubtype="fla" xml:lang="en"><item-info><jid>SCR</jid><aid>330</aid><ce:pii>S1873-5061(13)00111-6</ce:pii><ce:doi>10.1016/j.scr.2013.07.011</ce:doi><ce:copyright type="unknown" year="2013"/><ce:copyright-line>© 2013</ce:copyright-line></item-info><ce:floats><ce:figure id="f0005"><ce:label>Figure 1</ce:label><ce:caption id="ca0005"><ce:simple-para id="sp0015" view="all">Serial passaging of hiPSCs in static suspension in E8 medium. (a) Light microscope image of aggregates after 48<ce:hsp sp="0.25"/>h post-inoculation of single suspension BC1 cells in ultra-low attachment plates. (b) BC1 cells cultured in E8 medium, expanded in static suspension culture for 13 passages (45<ce:hsp sp="0.25"/>days, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3). (c) Flow cytometry plots (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) of TRA-1-60 expression in hiPSCs after 13 passages in static suspension. (d) Light microscope image of HPC-like single suspending cells emerging around a spin-EB on day 14. (e) Flow cytometry plots (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>2) of CD34 and CD45 expression in day-14 spin EBs. NC<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>negative control. Scale bars<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>200<ce:hsp sp="0.25"/>μm.</ce:simple-para></ce:caption><ce:link locator="gr1" id="lk0005"/></ce:figure><ce:figure id="f0010"><ce:label>Figure 2</ce:label><ce:caption id="ca0010"><ce:simple-para id="sp0020" view="all">Initiation and optimization of dynamic suspension culture in E8 medium. (a-c) 3-D CFD analysis of the velocity field at different agitating speeds in 100-ml glass-ball type spinner flasks. (a) Absolute value of velocity vectors of the fluid represented by heat map on two x-y slices at the agitating speed of 60<ce:hsp sp="0.25"/>rpm. (b) Vertical flow in the bioreactor at 40<ce:hsp sp="0.25"/>rpm. Heat plot on an x-z slice showed distribution of vertical flow. The sign of the value indicated directions of the vectors. Red solid lines were streamlines of the velocity field. (c) Heat map of shear stress distribution at the x-y slice. (d-g) Direct adaptation of BC1 cells in dynamic suspension culture from feeder-free adhesion culture at 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm, and 75<ce:hsp sp="0.25"/>rpm. (d) Representative images of the cells aggregates on day 1, day 3, and day 5 after seeded as single cells at different agitating speeds. Scale bars<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>200<ce:hsp sp="0.25"/>μm. (e) Box-and-whisker plot of the sizes of cell aggregates. (f) Growth curves of a 5-day culture in the first passage in spinner flask at 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm, and 75<ce:hsp sp="0.25"/>rpm. Means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3. *<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.05; **<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.01; ***<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001. (g) Cell viability along the 5-day culture (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3).</ce:simple-para></ce:caption><ce:link locator="gr2" id="lk0010"/></ce:figure><ce:figure id="f0015"><ce:label>Figure 3</ce:label><ce:caption id="ca0015"><ce:simple-para id="sp0025" view="all">Characterization of cell aggregates in spinner flasks. (a, b) Expression of the markers for undifferentiated state in BC1 cultured in spinner flasks. (a) Flow cytometry plot (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) of TRA-1-60<ce:sup loc="post">+</ce:sup>, SSEA4<ce:sup loc="post">+</ce:sup>, NANOG<ce:sup loc="post">+</ce:sup>, and OCT4<ce:sup loc="post">+</ce:sup> cells on day 5. Gray area represents isotype control. (b) Confocal microscope images of the immunofluorescence staining for OCT4 (in green) and SSEA4 (in red) at the center of z-slice of a cell aggregate on day 3. DAPI stained for nuclei. Scale bar<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>100<ce:hsp sp="0.25"/>μm. (c) A fitting curve of the cell number per aggregate to the diameter of the aggregate, means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.e.m., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>300-2000. (d) Flow cytometry plots (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>2) of TUNEL assay on day 3 aggregates, means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3, NC<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>negative control, PC<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>positive control. (e, f) Concentration of glucose and lactate (e) and pH (f) in the media samples. Note: the two data points on the same day represent the concentration before and after media change, means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3. (g) The pO<ce:inf loc="post">2</ce:inf> level as percentage of the O<ce:inf loc="post">2</ce:inf> saturation in three independent experiments (three colors).</ce:simple-para></ce:caption><ce:link locator="gr3" id="lk0015"/></ce:figure><ce:figure id="f0020"><ce:label>Figure 4</ce:label><ce:caption id="ca0020"><ce:simple-para id="sp0030" view="all">Serial passaging and expansion of hiPSCs in xeno-free condition in bioreactors. (a, b) The expansion fold (a) and the cell viability (b) at the end of each passage during the expansion of BC1 and TNC1. (c) The percentage of TRA-1-60<ce:sup loc="post">+</ce:sup>, SSEA4<ce:sup loc="post">+</ce:sup>, OCT4<ce:sup loc="post">+</ce:sup>, and NANOG<ce:sup loc="post">+</ce:sup> cells in the aggregates at the beginning of the suspension culture (passage 0) and along the culture period (passages 6, 13, 19, and 25). (d) G-banding karyotyping of BC1 and TNC1 after extensive culture in spinner flask (see detail in Supplementary methods). The TNC1 cell line had been undergone 5 times of freeze-thaw cycles in suspension culture.</ce:simple-para></ce:caption><ce:link locator="gr4" id="lk0020"/></ce:figure><ce:figure id="f0025"><ce:label>Figure 5</ce:label><ce:caption id="ca0025"><ce:simple-para id="sp0035" view="all">Differentiation potential of hiPSCs after prolonged expansion in bioreactors. (a) Immunofluorescence analysis of in vitro spontaneous differentiation of day-3 hiPSC aggregates. Germ cell markers (red): alpha-fetoprotein (AFP, endoderm), CD31 (mesoderm), and β-3-tubulin (ectoderm). (b) H&amp;E staining of biopsies of teratoma generated from hiPSCs in immunodeficient mice, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>2 for each cell line. Black arrows indicate glandular epithelium. (c) Exemplary microscope images and flow cytometry results of CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> cells from directed in vitro hematopoietic differentiation. The percentage of CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> cells is presented as mean<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3. (d) CFU assay. (i) Representative images of different types of colonies in CFU assay. BFU-E: burst-forming unit-erythroid; CFU-E: erythroid; CFU-GEMM: granulocyte-erythroid-macrophage-megakaryocyte, CFU-GM: macrophage-granulocyte. The hiPSCs cultured in spinner flasks (SF) were compared with the parallel feeder-free culture of the same cell line in adhesion (AD). The total number of CFU was analyzed by the two-tailed Student's <ce:italic>t</ce:italic>-test, means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3. Scale bars: 200<ce:hsp sp="0.25"/>μm.</ce:simple-para></ce:caption><ce:link locator="gr5" id="lk0025"/></ce:figure><ce:figure id="f0030"><ce:label>Figure 6</ce:label><ce:caption id="ca0030"><ce:simple-para id="sp0040" view="all">Cryopreservation and recovery of hiPSCs cultured in suspension. (a) Morphology of hiPSCs on day 3 after thawing either on Matrigel or VNT-N coated plates for adhesion culture, or in ultra-low attachment plates (UL) or in spinner flasks (SF) for dynamic suspension culture, respectively, from single-cell cryopreservation in E8-based freezing medium. Scale bars: 200<ce:hsp sp="0.25"/>μm. (b) The expansion of hiPSCs from cryopreservation following three protocols. AD-SF or UL-SF: thawing cells in adhesion or in UL, respectively, and transferred in SF at first splitting. SF: directly thawing cells in spinner flask. The significance of difference between UL-SF and SF on the first passage after thawing was analyzed by two-tailed Student's <ce:italic>t</ce:italic>-test, means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d., n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3. (c) Expression of TRA-1-60, SSEA4, OCT4, and NANOG at the end of passage 5 following a freeze-thaw cycle as determined by flow cytometry. (d) hiPSCs recovered from UL-SF protocol at passage 5 after thaw kept the potential to differentiate into CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> HPCs. (e) G-banding karyotyping of BC1 cells after total 72 passages with 30 passages on MEF, 24 passages on VNT-N, and 18 passages in suspension, and at least 5 times of freeze-thaw cycles.</ce:simple-para></ce:caption><ce:link locator="gr6" id="lk0030"/></ce:figure><ce:figure id="f0035"><ce:label>Figure 7</ce:label><ce:caption id="ca0035"><ce:simple-para id="sp0045" view="all">Schematic presentation of the cryopreservation and scale-up expansion of hiPSCs in xeno-free culture system. The days and the yield of hiPSCs are presented as approximate amount. Drawing not to scale.</ce:simple-para></ce:caption><ce:link locator="gr7" id="lk0035"/></ce:figure></ce:floats><head><ce:article-footnote><ce:label>☆</ce:label><ce:note-para id="np0005" view="all">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</ce:note-para></ce:article-footnote><ce:title id="ti0005">Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions</ce:title><ce:author-group id="ag0005"><ce:author id="au0005"><ce:given-name>Ying</ce:given-name><ce:surname>Wang</ce:surname><ce:cross-ref refid="af0005" id="cf0005"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="af0010" id="cf0010"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="af0030" id="cf0015"><ce:sup loc="post">f</ce:sup></ce:cross-ref></ce:author><ce:author id="au0010"><ce:given-name>Bin-Kuan</ce:given-name><ce:surname>Chou</ce:surname><ce:cross-ref refid="af0010" id="cf0020"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="af0015" id="cf0025"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0015"><ce:given-name>Sarah</ce:given-name><ce:surname>Dowey</ce:surname><ce:cross-ref refid="af0010" id="cf0030"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="af0020" id="cf0035"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0020"><ce:given-name>Chaoxia</ce:given-name><ce:surname>He</ce:surname><ce:cross-ref refid="af0010" id="cf0040"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="af0020" id="cf0045"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0025"><ce:given-name>Sharon</ce:given-name><ce:surname>Gerecht</ce:surname><ce:cross-ref refid="af0005" id="cf0050"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="af0025" id="cf0055"><ce:sup loc="post">e</ce:sup></ce:cross-ref><ce:cross-ref refid="af0030" id="cf0060"><ce:sup loc="post">f</ce:sup></ce:cross-ref><ce:cross-ref refid="cr0005" id="cf0065"><ce:sup loc="post">⁎</ce:sup></ce:cross-ref><ce:e-address id="em0005" type="email">gerecht@jhu.edu</ce:e-address></ce:author><ce:author id="au0030"><ce:given-name>Linzhao</ce:given-name><ce:surname>Cheng</ce:surname><ce:cross-ref refid="af0010" id="cf0070"><ce:sup loc="post">b</ce:sup></ce:cross-ref><ce:cross-ref refid="af0020" id="cf0075"><ce:sup loc="post">d</ce:sup></ce:cross-ref><ce:cross-ref refid="cr0010" id="cf0080"><ce:sup loc="post">⁎⁎</ce:sup></ce:cross-ref><ce:e-address id="em0010" type="email">lcheng2@jhmi.edu</ce:e-address></ce:author><ce:affiliation id="af0005"><ce:label>a</ce:label><ce:textfn id="tn0005">Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA</ce:textfn><sa:affiliation><sa:organization>Department of Chemical and Biomolecular Engineering</sa:organization><sa:organization>The Johns Hopkins University</sa:organization><sa:address-line>3400 N. Charles St.</sa:address-line><sa:city>Baltimore</sa:city><sa:state>MD</sa:state><sa:postal-code>21218</sa:postal-code><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id="af0010"><ce:label>b</ce:label><ce:textfn id="tn0010">Stem Cell Program, Institute of Cell Engineering, The Johns Hopkins University School of Medicine, Edward D. Miller Research Building, Room 747, 733 N. Broadway, Baltimore, MD 21205, USA</ce:textfn><sa:affiliation><sa:organization>Stem Cell Program</sa:organization><sa:organization>Institute of Cell Engineering</sa:organization><sa:organization>The Johns Hopkins University School of Medicine</sa:organization><sa:address-line>Edward D. Miller Research Building</sa:address-line><sa:address-line>Room 747</sa:address-line><sa:address-line>733 N. Broadway</sa:address-line><sa:city>Baltimore</sa:city><sa:state>MD</sa:state><sa:postal-code>21205</sa:postal-code><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id="af0015"><ce:label>c</ce:label><ce:textfn id="tn0015">Graduate Program of Molecular and Cellular Medicine, The Johns Hopkins University School of Medicine, USA</ce:textfn><sa:affiliation><sa:organization>Graduate Program of Molecular and Cellular Medicine</sa:organization><sa:organization>The Johns Hopkins University School of Medicine</sa:organization><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id="af0020"><ce:label>d</ce:label><ce:textfn id="tn0020">Division of Hematology, Department of Medicine, The Johns Hopkins University, Edward D. Miller Research Building, Room 747, 733 N. Broadway, Baltimore, MD 21205, USA</ce:textfn><sa:affiliation><sa:organization>Division of Hematology</sa:organization><sa:organization>Department of Medicine</sa:organization><sa:organization>The Johns Hopkins University</sa:organization><sa:address-line>Edward D. Miller Research Building</sa:address-line><sa:address-line>Room 747</sa:address-line><sa:address-line>733 N. Broadway</sa:address-line><sa:city>Baltimore</sa:city><sa:state>MD</sa:state><sa:postal-code>21205</sa:postal-code><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id="af0025"><ce:label>e</ce:label><ce:textfn id="tn0025">Department of Material Sciences and Engineering, The Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA</ce:textfn><sa:affiliation><sa:organization>Department of Material Sciences and Engineering</sa:organization><sa:organization>The Johns Hopkins University</sa:organization><sa:address-line>3400 N. Charles St.</sa:address-line><sa:city>Baltimore</sa:city><sa:state>MD</sa:state><sa:postal-code>21218</sa:postal-code><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id="af0030"><ce:label>f</ce:label><ce:textfn id="tn0030">Institute for NanoBioTechnology, The Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA</ce:textfn><sa:affiliation><sa:organization>Institute for NanoBioTechnology</sa:organization><sa:organization>The Johns Hopkins University</sa:organization><sa:address-line>3400 N. Charles St.</sa:address-line><sa:city>Baltimore</sa:city><sa:state>MD</sa:state><sa:postal-code>21218</sa:postal-code><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:correspondence id="cr0005"><ce:label>⁎</ce:label><ce:text id="tx0005">Correspondence to: S. Gerecht, Department of Chemical and Biomolecular Engineering, and Institute for NanoBioTechnology, The Johns Hopkins University. 3400 N. Charles St. Baltimore, MD 21218, USA. Fax: +<ce:hsp sp="0.10"/>1 410 516 5510.</ce:text></ce:correspondence><ce:correspondence id="cr0010"><ce:label>⁎⁎</ce:label><ce:text id="tx0010">Correspondence to: L. Cheng, Stem Cell Program, Institute of Cell Engineering, The Johns Hopkins University School of Medicine, Edward D. Miller Research Building, Room 747, 733 N. Broadway, Baltimore, MD 21205, USA. Fax: +<ce:hsp sp="0.10"/>1 443 287 5611.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="22" month="3" year="2013"/><ce:date-revised day="29" month="7" year="2013"/><ce:date-accepted day="31" month="7" year="2013"/><ce:abstract id="ab0005" view="all" class="author"><ce:section-title id="st0005">Abstract</ce:section-title><ce:abstract-sec id="as0005" view="all"><ce:simple-para id="sp0005" view="all">Large-scale production of human induced pluripotent stem cells (hiPSCs) by robust and economic methods has been one of the major challenges for translational realization of hiPSC technology. Here we demonstrate a scalable culture system for hiPSC expansion using the E8 chemically defined and xeno-free medium under either adherent or suspension conditions. To optimize suspension conditions guided by a computational simulation, we developed a method to efficiently expand hiPSCs as undifferentiated aggregates in spinner flasks. Serial passaging of two different hiPSC lines in the spinner flasks using the E8 medium preserved their normal karyotype and expression of undifferentiated state markers of TRA-1-60, SSEA4, OCT4, and NANOG. The hiPSCs cultured in spinner flasks for more than 10 passages not only could be remained pluripotent as indicated by in vitro and in vivo assays, but also could be efficiently induced toward mesodermal and hematopoietic differentiation. Furthermore, we established a xeno-free protocol of single-cell cryopreservation and recovery for the scalable production of hiPSCs in spinner flasks. This system is the first to enable an efficient scale-up bioprocess in completely xeno-free condition for the expansion and cryopreservation of hiPSCs with the quantity and quality compliant for clinical applications.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="ab0010" view="all"><ce:section-title id="st0010">Highlights</ce:section-title><ce:abstract-sec id="as0010" view="all"><ce:simple-para id="sp0010" view="all"><ce:list id="l0005"><ce:list-item id="u0005"><ce:label>•</ce:label><ce:para id="p0305" view="all">We report the first suspension culture of hiPSCs using E8 medium.</ce:para></ce:list-item><ce:list-item id="u0010"><ce:label>•</ce:label><ce:para id="p0310" view="all">We report the first hydrodynamic model for glass-ball type spinner flasks.</ce:para></ce:list-item><ce:list-item id="u0015"><ce:label>•</ce:label><ce:para id="p0315" view="all">We establish a scalable bioprocess in completely defined xeno-free conditions.</ce:para></ce:list-item><ce:list-item id="u0020"><ce:label>•</ce:label><ce:para id="p0320" view="all">We optimized a single-cell cryopreservation for hiPSCs in suspension.</ce:para></ce:list-item><ce:list-item id="u0025"><ce:label>•</ce:label><ce:para id="p0325" view="all">Human iPSCs maintained pluripotency and normal karyotype along the bioprocess.</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract></head><body view="all"><ce:sections><ce:section id="s0005" view="all"><ce:section-title id="st0020">Introduction</ce:section-title><ce:para id="p0005" view="all">Human pluripotent stem cells (hPSCs), including human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) that can differentiate into any mature cell type of the body, hold great promise for revolutionizing regenerative medicine. Specifically, the integration-free reprogramming technologies, such as ones using plasmids, provide a feasible method to generate autologous and clinical-grade hiPSC lines for therapeutic applications under current good manufacture practice (cGMP) conditions. Patient-specific hiPSC lines derived from postnatal somatic cells (<ce:cross-refs refid="bb0005 bb0010 bb0015" id="cf0130">Chou et al., 2011; Dowey et al., 2012; Ye et al., 2009</ce:cross-refs>) exhibit vast potential not only in disease modeling for pathological studies but also in practical cellular therapies. These clinical applications require a large number of hiPSCs or their progenies. For example, an optimized dose was suggested to contain 4.2<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">8</ce:sup> to 5.6<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">8</ce:sup> CD34<ce:sup loc="post">+</ce:sup> cells for hematopoietic stem cell (HSC) transplantation for a 70-kg adult patient (<ce:cross-ref refid="bb0020" id="cf0090">Mehta et al., 2009</ce:cross-ref>). Production of a clinically relevant quantity of hiPSCs and/or their progenies for specific applications, sometimes considered as ~<ce:hsp sp="0.10"/>1 to 2<ce:hsp sp="0.25"/>billion (<ce:cross-ref refid="bb0025" id="cf0095">Kehoe et al., 2010</ce:cross-ref>), in a chemically defined condition by robust, reproducible and economic methods remains a major challenge for advancing hiPSC technology from the bench to the clinic.</ce:para><ce:para id="p0010" view="all">Conventionally, hiPSCs are induced and expanded on feeder cells as adherent colonies in media containing sera or serum replacement containing human or animal serum albumin (<ce:cross-refs refid="bb0030 bb0035" id="cf0100">Okita et al., 2007; Yu et al., 2007</ce:cross-refs>). The involvement of animal products or sera impedes these culture conditions to meet the strict requirement of clinical or pre-clinical utilization because of the uncertainty of complex components and the quality variance from batch to batch. Since the first isolation of hiPSCs, significant improvements in feeder- and serum-free chemically defined culture medium and substrates for adherent hiPSC culture have been developed (<ce:cross-refs refid="bb0040 bb0045 bb0050 bb0055 bb0060" id="cf0105">Chen et al., 2011; Li et al., 2005; Ludwig et al., 2006; Vallier et al., 2005; Wang et al., 2007</ce:cross-refs>). However, these approaches involving adherent culture of hiPSCs in Petri dishes still raise a major hurdle of large scale and well-controlled expansion for clinical use.</ce:para><ce:para id="p0015" view="all">Suspension culture for hiPSC expansion provides a feasible solution for its scale-up capacity. After a Rho-associated-coiled-coil kinase (ROCK) inhibitor Y27632 was reported to permit the survival of dissociated hESCs when supplemented in the medium only on the first day of seeding (<ce:cross-ref refid="bb0065" id="cf0110">Watanabe et al., 2007</ce:cross-ref>), detailed protocols were established for the single-cell inoculation and suspension culture of hPSCs as cell aggregates in a variety of vessel types (<ce:cross-refs refid="bb0070 bb0075 bb0080" id="cf0115">Amit et al., 2011; Olmer et al., 2010; Zweigerdt et al., 2011</ce:cross-refs>). Other studies have also reported successful suspension culture in spinner flasks in 100-ml vessels (<ce:cross-refs refid="bb0085 bb0090 bb0095 bb0100 bb0105 bb0110 bb0115" id="cf0120">Abbasalizadeh et al., 2012; Chen et al., 2012; Fluri et al., 2012; Krawetz et al., 2010; Olmer et al., 2012; Singh et al., 2010; Steiner et al., 2010</ce:cross-refs>). Despite the rapid development of hPSC suspension culture in these studies, most of the reproducible systems are based on commercially available serum-free media, StemPro or mTeSR, which are complex and expensive. The unknown composition (such as StemPro) and high cost of these media pose a major concern for developing reproducible methods for large-scale expansion of hiPSCs.</ce:para><ce:para id="p0020" view="all">Chen et al. recently reported the development of a significantly improved hiPSC culture medium, E8, which contains only seven other completely defined and xeno-free components supplementing the standard DMEM/F-12 medium (<ce:cross-ref refid="bb0040" id="cf0125">Chen et al., 2011</ce:cross-ref>). We did confirm that this significantly improved medium without the need to add bovine serum albumin (BSA) Fraction V or human albumin supported the growth of multiple hiPSC lines under feeder-free conditions in adhesion. Based on this, we sought to test whether the significantly simplified E8 medium could support a robust and economic suspension culture system in a stirred bioreactor for large-scale expansion and cryopreservation of hiPSCs. Here, we used two integration-free hiPSC lines, BC1 and TNC1, which were derived from leukocytes of either a healthy donor or a sickle cell disease patient using plasmid-based episomal vectors (<ce:cross-ref refid="bb0005" id="cf2130">Chou et al., 2011</ce:cross-ref>). We began by evaluating the capacity of E8 medium to support the expansion of hiPSCs in static suspension cultures. We then optimized the operating protocol for direct adaptation and expansion of the hiPSCs in spinner flasks using computational simulation of the hydrodynamic properties and experimental tests. Furthermore, we tested serial passaging and differentiation potential of hiPSCs expanded in spinner flasks. Finally, xeno-free cryopreservation and recovery methods were established for hiPSCs cultured in the bioreactor.</ce:para></ce:section><ce:section id="s0020" view="all"><ce:section-title id="st0040">Materials and methods</ce:section-title><ce:section id="s0070" view="all"><ce:section-title id="st0095">Maintenance of hiPSCs in adhesion</ce:section-title><ce:para id="p0175" view="all">Human iPSC lines BC1 and TNC1 were initially maintained on mouse embryonic fibroblast (MEF) feeders in standard ESC medium as previously described (<ce:cross-ref refid="bb0005" id="cf0135">Chou et al., 2011</ce:cross-ref>). At passage 30-32, BC1 cells were dissociated using 0.5<ce:hsp sp="0.25"/>mM EDTA in calcium- and magnesium-free PBS (<ce:cross-ref refid="bb0195" id="cf0140">Beers et al., 2012</ce:cross-ref>), and directly adapted onto tissue culture plates coated with Matrigel (MG, 1.67<ce:hsp sp="0.25"/>μg/cm<ce:sup loc="post">2</ce:sup>, BD) or truncated recombinant human vitronectin (VNT-N, 5<ce:hsp sp="0.25"/>μg/cm<ce:sup loc="post">2</ce:sup>, Invitrogen) in E8 medium (home-made as described by <ce:cross-ref refid="bb0040" id="cf0145">Chen et al. (2011)</ce:cross-ref> or Essential 8 from Invitrogen) supplemented with 10<ce:hsp sp="0.25"/>μM ROCK inhibitor Y27632 (Stemgent) for 24<ce:hsp sp="0.25"/>h. Medium was changed daily. Cells were routinely passaged as small clumps using EDTA method (<ce:cross-ref refid="bb0195" id="cf0150">Beers et al., 2012</ce:cross-ref>) or as single cells using Accutase (Sigma-Aldrich) with the split ratio of 1:8 to 1:12 every 2 to 3<ce:hsp sp="0.25"/>days after reaching 60% to 80% confluence.</ce:para></ce:section><ce:section id="s0075" view="all"><ce:section-title id="st0100">Suspension culture of hiPSCs</ce:section-title><ce:para id="p0185" view="all">BC1 and TNC1 were cultured in feeder-free adhesion culture for at least 5 passages before transfer in suspension culture. Prior to the passage, hiPSCs were treated with Y27632 for 1<ce:hsp sp="0.25"/>h and dissociated with pre-warmed Accutase for 2 to 3<ce:hsp sp="0.25"/>min in 37<ce:hsp sp="0.25"/>°C. After gentle pipetting, the single cell solution was diluted 1:10 with DMEM/F-12, and centrifuged at 200<ce:hsp sp="0.25"/><ce:italic>g</ce:italic> for 5<ce:hsp sp="0.25"/>min. Cells were resuspended by adding E8 medium with 10<ce:hsp sp="0.25"/>μM Y27632 and plated at a density of 1.5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup> to 2.0<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml in ultra-low attachment plates or seeded at 4<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup> to 5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml. Daily medium change was performed by replacing 70% of the medium with fresh E8 medium without ROCK inhibitor. Cells were cultured in static condition or in spinner flasks (CELLSPIN system of 100<ce:hsp sp="0.25"/>ml capacity with a single glass-ball stirring pendulum, Integra Bio-sciences) in standard 5% CO<ce:inf loc="post">2</ce:inf> incubator at 37<ce:hsp sp="0.25"/>°C and passaged every 3 to 4<ce:hsp sp="0.25"/>days using Accutase as aforementioned.</ce:para></ce:section><ce:section id="s0080" view="all"><ce:section-title id="st0105">Analysis for aggregates and metabolism</ce:section-title><ce:para id="p0195" view="all">Samples of cell aggregates were analyzed for cell number, viability, and metabolic products. Briefly, 0.5 to 1.5<ce:hsp sp="0.25"/>ml of samples were taken and placed still for 5<ce:hsp sp="0.25"/>min. Supernatants were filtered, stored in -<ce:hsp sp="0.10"/>20<ce:hsp sp="0.25"/>°C, and tested for glucose, lactate, and pH in a blood gas analyzer (Radiometer, ABL 710 at Department of Radiology, Johns Hopkins Medical Institute). Light microscopy images were captured using Axiovert phase contrast microscope (Zeiss). The total number of cell aggregates <ce:italic>N</ce:italic><ce:inf loc="post">agg</ce:inf> in a 1-ml sample was analyzed by using the "Embryoid body analysis" module in Celigo imaging cytometer (Brooks). The average equivalent diameter of aggregates <ce:italic>d</ce:italic> and the size of each aggregate in the sample were also measured in this analysis. For counting the cell number in a 1-ml sample <ce:italic>N</ce:italic><ce:inf loc="post">cell</ce:inf> and the cell viability, cell aggregates were dissociated by Accutase, stained with 0.4% Trypan blue, and counted by Countess automated cell counter (Life Technologies). The average cell number per aggregate <ce:italic>N</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/><ce:italic>N</ce:italic><ce:inf loc="post">cell</ce:inf><ce:hsp sp="0.25"/>/<ce:hsp sp="0.25"/><ce:italic>N</ce:italic><ce:inf loc="post">agg</ce:inf> was calculated in 8 samples containing aggregates in different average diameters <ce:italic>d</ce:italic> from three independent culture cycles. In the plot of <ce:italic>N</ce:italic>-<ce:italic>d</ce:italic> (<ce:cross-ref refid="f0015" id="cf0155">Fig. 3</ce:cross-ref>c), the data points fit best to a 3rd-order polynomial, defined by having the smallest <ce:italic>R</ce:italic><ce:sup loc="post">2</ce:sup> value comparing to other fitting functions. Dissolved oxygen (DO) level in the suspension medium was monitored real-time using a non-invasive optical fiber probe and PSt3 sensor spots via Oxy-4 mini transmitter (PreSens).</ce:para></ce:section><ce:section id="s0085" view="all"><ce:section-title id="st0110">Flow cytometry</ce:section-title><ce:para id="p0205" view="all">See Supplementary methods.</ce:para></ce:section><ce:section id="s0090" view="all"><ce:section-title id="st0115">Immunofluorescent staining of hiPSCs in adhesion</ce:section-title><ce:para id="p0215" view="all">See Supplementary methods.</ce:para></ce:section><ce:section id="s0095" view="all"><ce:section-title id="st0120">Immunofluorescent staining of cell aggregates in suspension culture</ce:section-title><ce:para id="p0225" view="all">Whole aggregate staining was performed for immunofluorescence microscopy as described before (<ce:cross-ref refid="bb0090" id="cf0160">Chen et al., 2012</ce:cross-ref>). Fluorescent images of whole cell aggregates were captured and analyzed by LSM 510 META confocal microscope (Zeiss).</ce:para></ce:section><ce:section id="s0100" view="all"><ce:section-title id="st0125">Karyotyping</ce:section-title><ce:para id="p0235" view="all">Karyotype of hiPSCs was examined by a certified cytogeneticist using G-banding (300-500<ce:hsp sp="0.25"/>bands) method as previously described (<ce:cross-ref refid="bb0005" id="cf0165">Chou et al., 2011</ce:cross-ref>). At least 20 metaphases were checked for each sample. For example, the passage number of BC1 p30<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>21<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>21 (see <ce:cross-ref refid="f0020" id="cf0170">Fig. 4</ce:cross-ref>d) means that the examined BC1 cells have been cultured for 30 passages on MEF, followed by 21 passages on VNT-N and 21 passages in bioreactor. For TNC1 p30<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>17<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>19, there have been 30 passages on MEF, 17 passages on Matrigel, and 19 passages in bioreactor.</ce:para><ce:section id="s0105" view="all"><ce:section-title id="st0130">In vitro hematopoietic differentiation</ce:section-title><ce:para id="p0245" view="all">Human iPSCs were differentiated into hematopoietic stem cells (HSCs, CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> cells) using spin-embryoid body (spin-EB) method in feeder- and serum-free conditions as described before (<ce:cross-refs refid="bb0135 bb0140 bb0145" id="cf0175">Ng et al., 2008, 2005; Yu et al., 2008</ce:cross-refs>). The EBs were harvested on day 14 of differentiation. Single cells were isolated and analyzed by flow cytometry for the presence of hematopoietic markers and hematopoietic CFU assay as previously described (<ce:cross-refs refid="bb0145 bb0150" id="cf0180">Yu et al., 2008; Zhan et al., 2004</ce:cross-refs>).</ce:para></ce:section><ce:section id="s0110" view="all"><ce:section-title id="st0135">In vitro spontaneous differentiation of germ cells</ce:section-title><ce:para id="p0255" view="all">Single cells were seeded in ultra-low-attachment plates in ESC medium supplemented with 10% fetal bovine serum (FBS, HyClone) at 3.3<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml to initiate EB formation. For iPSCs maintained in suspension in spinner flasks, cell aggregates were washed, and the entire medium was changed from E8 to differentiation medium to induce transformation from cell aggregates to EBs on day 3 after passaging. After 8<ce:hsp sp="0.25"/>days, EBs were transferred onto gelatin-coated plates and attached. Differentiated cells on day 12 were stained for fluorescence microscopy as described.</ce:para></ce:section><ce:section id="s0115" view="all"><ce:section-title id="st0140">Teratoma formation assay</ce:section-title><ce:para id="p0265" view="all">The use of immunocompromised mice for teratoma formation assay was approved by the Animal Care and Use Committee in Johns Hopkins University. The assay was performed as described before (<ce:cross-ref refid="bb0005" id="cf0185">Chou et al., 2011</ce:cross-ref>). See more details in the Supplementary methods.</ce:para></ce:section><ce:section id="s0120" view="all"><ce:section-title id="st0145">Cryopreservation and recovery of hiPSCs in suspension culture</ce:section-title><ce:para id="p0275" view="all">Cell aggregates on day 2 or day 3 were pre-treated with 10<ce:hsp sp="0.25"/>μM Y27632 for 1<ce:hsp sp="0.25"/>h and dissociated into a single cell suspension with Accutase. After washing with PBS once, cells were suspended in E8<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>10<ce:hsp sp="0.25"/>μM Y27632 and distributed into Cryovial aliquots. The same amount of E8<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>Y27632<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>20% (in volume) DMSO cryopreservation medium was added dropwise. Cells were immediately frozen at -<ce:hsp sp="0.10"/>80<ce:hsp sp="0.25"/>°C in isopropanol freezing containers overnight, and transferred to liquid nitrogen for storage. For recovery from frozen stock, the cells were thawed by following standard cell culture protocol. Single cells were seeded at 5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">4</ce:sup><ce:hsp sp="0.25"/>cells/cm<ce:sup loc="post">2</ce:sup> in either Matrigel- or VNT-N-coated 150-cm<ce:sup loc="post">2</ce:sup> flasks or ultra-low attachment plates, or at 5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml directly in spinner flasks at agitating speed of 60<ce:hsp sp="0.25"/>rpm. The aforementioned culture and passaging protocols were followed afterwards.</ce:para></ce:section><ce:section id="s0125" view="all"><ce:section-title id="st0150">Computational fluid dynamics (CFD) analysis</ce:section-title><ce:para id="p0285" view="all">See Supplementary methods.</ce:para></ce:section><ce:section id="s0130" view="all"><ce:section-title id="st0155">Data presentation and statistics</ce:section-title><ce:para id="p0295" view="all">For flow cytometry analysis, 20,000 events were collected and analyzed. Selected cell populations were shown as a percentage among the total gated live cells, based on the comparison with background staining shown when isotype controls of corresponding antibodies were used. Data of cell number, viability, pH of the medium, and glucose and lactate concentrations, were collected from at least three independent repeats (n<ce:hsp sp="0.25"/>≥<ce:hsp sp="0.25"/>3), and all measurements were done in duplicates or triplicates to avoid sampling error. Results were reported as mean<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>s.d. if not specified. The two-tailed Student's <ce:italic>t</ce:italic>-test or two-way analysis of variance (two-way ANOVA) was performed with GraphPad Prism 5 for comparison between two groups or multiple groups, respectively. Significance level was set as *<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.05, **<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.01, and ***<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.001.</ce:para></ce:section></ce:section></ce:section><ce:section id="s0010" view="all"><ce:section-title id="st0025">Results</ce:section-title><ce:section id="s0025" view="all"><ce:section-title id="st0050">Adaptation and robust growth in feeder-free adhesion culture</ce:section-title><ce:para id="p0030" view="all">To prevent contamination of feeder cells in suspension culture, we first acclimated hiPSCs expanded in conventional mouse embryonic fibroblast (MEF) culture conditions (<ce:cross-ref refid="bb0005" id="cf0190">Chou et al., 2011</ce:cross-ref>) into feeder-free condition. BC1 and TNC1 were transferred directly to E8 medium (<ce:cross-ref refid="bb0040" id="cf0195">Chen et al., 2011</ce:cross-ref>) on culture plates coated with diluted Matrigel or on purified recombinant vitronectin (VNT-N) substrate (<ce:cross-ref refid="bb0040" id="cf0200">Chen et al., 2011</ce:cross-ref>). We found that a step-by-step adaptation process, which is typically associated with other feeder-free conditions (<ce:cross-refs refid="bb0120 bb0125 bb0130" id="cf0205">Bigdeli et al., 2008; Desbordes and Studer, 2013; Stover and Schwartz, 2011</ce:cross-refs>), is not required when we switched to E8 feeder-free conditions. Culture on either Matrigel or VNT-N supports robust and long-term culture of adherent, undifferentiated hiPSCs as a monolayer in adhesion (Supplementary Fig. S1a-e). The hiPSCs were routinely passaged in single cells (using Accutase) or in small clumps (by EDTA) (<ce:cross-ref refid="bb0040" id="cf0210">Chen et al., 2011</ce:cross-ref>) at a split ratio of 1:8 to 1:12 every 3 to 4<ce:hsp sp="0.25"/>days. They expressed TRA-1-60, SSEA4, OCT4, and NANOG, which are markers for undifferentiated hPSCs (Supplementary Fig. S1c-e). After more than 30 passages cultured in E8 medium and feeder-free conditions, hiPSCs maintained normal karyotype (Supplementary Fig. S1f). These hiPSCs were able to form embryoid bodies (EBs) in vitro containing cells from all three germ layers (Supplementary Fig. S2a), confirming that the hiPSCs retained their pluripotency. We also examined directed hematopoietic differentiation of BC1 and TNC1 cultured under the E8 feeder-free conditions for at least 10 passages. Using the spin-EB method (<ce:cross-refs refid="bb0135 bb0140 bb0145" id="cf0215">Ng et al., 2008, 2005; Yu et al., 2008</ce:cross-refs>) in a feeder- and serum-free condition, we found that on day 14, ~<ce:hsp sp="0.10"/>25%-80% of the differentiating hiPSCs were CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> characteristic of hematopoietic progenitor cells (HPCs) (Supplementary Fig. S2b). Moreover, hiPSCs expanded in E8 feeder-free condition showed comparable potential to generate multiple hematopoietic lineages as hiPSCs expanded in MEF culture conditions in the standard colony-forming unit (CFU) assay (<ce:cross-refs refid="bb0145 bb0150" id="cf0220">Yu et al., 2008; Zhan et al., 2004</ce:cross-refs>) (Supplementary Fig. S2c).</ce:para></ce:section><ce:section id="s0030" view="all"><ce:section-title id="st0055">Serial passaging and expansion in static suspension culture</ce:section-title><ce:para id="p0040" view="all">It has not been reported whether the significantly simplified E8 medium is sufficient to support the survival and proliferation of undifferentiated hPSCs in suspension culture. Thus our studies began by establishing a static suspension culture condition in E8 medium for serial passaging and expansion of hiPSCs. BC1 cells cultured on E8 feeder-free conditions (E8-Matrigel or E8-VNT-N) for at least 3 passages were seeded as a single cell suspension in E8 medium supplemented with Y27632 on the first day (<ce:cross-ref refid="bb0065" id="cf0225">Watanabe et al., 2007</ce:cross-ref>). The cells survived and formed convex dish-shaped aggregates within 24<ce:hsp sp="0.25"/>h due to the gravity force (<ce:cross-ref refid="f0005" id="cf0230">Fig. 1</ce:cross-ref>a<ce:float-anchor refid="f0005"/>). The size of the cell aggregates gradually increased corresponding to the cell number along the culture period. BC1 cells expanded in static suspension in E8 medium with an average rate of 3.7<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.9 fold per passage, 3.7<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">6</ce:sup> fold increase in total with &gt;<ce:hsp sp="0.10"/>99% of the cells being TRA-1-60<ce:sup loc="post">+</ce:sup> after 13 passages (<ce:cross-ref refid="f0005" id="cf0235">Fig. 1</ce:cross-ref>b,c). We also examined the differentiation potential of expanded cells, using the spin-EB method (<ce:cross-refs refid="bb0135 bb0140 bb0145" id="cf0240">Ng et al., 2008, 2005; Yu et al., 2008</ce:cross-refs>). We found that under the hematopoiesis-inducing condition, leukocyte-like cells emerged around day 10 (<ce:cross-ref refid="f0005" id="cf0245">Fig. 1</ce:cross-ref>d) with 46.8%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>1.6% of the cells becoming CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> HPCs (<ce:cross-ref refid="f0005" id="cf0250">Fig. 1</ce:cross-ref>e). These results indicate that undifferentiated hiPSCs can be expanded in suspension in E8 medium supplemented with one-day treatment of Y27632, and retain their differentiation potential.</ce:para></ce:section><ce:section id="s0035" view="all"><ce:section-title id="st0060">Initiation of dynamic suspension culture of hiPSCs</ce:section-title><ce:section id="s0040" view="all"><ce:section-title id="st0065">Computational fluid dynamics (CFD) analysis of glass-ball spinner flask</ce:section-title><ce:para id="p0055" view="all">Previous studies suggest that an adaptation of hPSCs expanded in adherent culture to suspension culture in static conditions is needed prior to inoculation in dynamic suspension culture (<ce:cross-refs refid="bb0070 bb0080 bb0085" id="cf0255">Amit et al., 2011; Zweigerdt et al., 2011; Abbasalizadeh et al., 2012</ce:cross-refs>). To support a robust production of hiPSCs from the bench to a clinical setting, we sought to adapt the cells directly from feeder-free adhesion culture to dynamic suspension culture in spinner flasks. A key parameter of spinner flasks to control is the agitation forces, which should be sufficient to ensure homogeneous distribution of cell aggregates, nutrients and oxygen, but not too severe to harm the cells. Human PSCs are sensitive to high shear stress that may cause unexpected cell death (<ce:cross-refs refid="bb0025 bb0085" id="cf0260">Kehoe et al., 2010; Abbasalizadeh et al., 2012</ce:cross-refs>) and differentiation (<ce:cross-refs refid="bb0155 bb0160" id="cf0265">Adamo et al., 2009; Yamamoto et al., 2005</ce:cross-refs>). Thus the velocity field profile and the shear stress distribution in the vessel are major considerations in the bioreactor design and setting for suspension culture of hPSCs. Spinner flasks equipped with pendulum-shaped (glass-ball) impellers were advantageous compared to other impeller types in previous studies (<ce:cross-refs refid="bb0080 bb0165" id="cf0270">Zweigerdt et al., 2011; Yirme et al., 2008</ce:cross-refs>) that might be due to mild shear stress generated by the smooth surface. Therefore, we chose the CELLSPIN system with a 100-ml spinner flask equipped with a single glass-ball stirring pendulum as the platform for hiPSC suspension culture. To predict the hydrodynamic property, we performed computational fluid dynamics (CFD) analysis for a 3-D model of the glass-ball spinner flask (see Supplementary methods). The physical properties of 37<ce:hsp sp="0.25"/>°C pure water were applied to approximate the properties of a single cell suspension in E8 medium during the first 12<ce:hsp sp="0.25"/>h after inoculation when the cells are most vulnerable to high shear stress. The simulation of the steady-state CFD at agitating speeds of 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm and 75<ce:hsp sp="0.25"/>rpm (maximum spinning speed available of the system) was performed. A stable flow profile was found in all agitating speeds examined without inadequate mixing or large disturbing turbulence (representatively showing 60<ce:hsp sp="0.25"/>rpm, <ce:cross-ref refid="f0010" id="cf0275">Fig. 2</ce:cross-ref>a<ce:float-anchor refid="f0010"/>). Highest local Reynolds number, <ce:italic>Re</ce:italic>, was found at the small area tracking the rotating pendulum, which increased from laminar flow regime (<ce:italic>Re</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>1000) to laminar-turbulent transition regime (1000<ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/><ce:italic>Re</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>2000) (<ce:cross-refs refid="bb0170 bb0175" id="cf0280">O'Connor and Terry Papoutsakis, 1992; Sucosky et al., 2004</ce:cross-refs>) as the agitating speed increased (Supplementary Fig. S3a). The profile of the z-direction velocity and the streamline indicated that even at the lowest agitation speed of 40<ce:hsp sp="0.25"/>rpm, the rotating pendulum provides appropriate convective flow in the vertical direction that enhances the mass transfer (<ce:cross-ref refid="f0010" id="cf0285">Fig. 2</ce:cross-ref>b). At the maximum spinning speed, 75<ce:hsp sp="0.25"/>rpm, the highest shear stress was determined as 0.152<ce:hsp sp="0.25"/>N/m<ce:sup loc="post">2</ce:sup> (1.52<ce:hsp sp="0.25"/>dyn/cm<ce:sup loc="post">2</ce:sup>) at the point near the farthest reach of the glass ball from the spinning axis (<ce:cross-ref refid="f0010" id="cf0290">Fig. 2</ce:cross-ref>c). This shear stress level is lower than spinner flasks equipped with other types of impellers, such as pitched-blade impeller (2-5.2<ce:hsp sp="0.25"/>dyn/cm<ce:sup loc="post">2</ce:sup>, 50-100<ce:hsp sp="0.25"/>rpm) (<ce:cross-ref refid="bb0180" id="cf0295">Cormier et al., 2006</ce:cross-ref>) and paddled impeller (4.5-7.8<ce:hsp sp="0.25"/>dyn/cm<ce:sup loc="post">2</ce:sup>, 80-120<ce:hsp sp="0.25"/>rpm) (<ce:cross-refs refid="bb0025 bb0185" id="cf0300">Kehoe et al., 2010; Li et al., 2009</ce:cross-refs>), indicating mild hydrodynamic impact on the cells.</ce:para></ce:section><ce:section id="s0045" view="all"><ce:section-title id="st0070">Optimization of agitating speed and cell split interval</ce:section-title><ce:para id="p0065" view="all">BC1 cells cultured in E8-Matrigel condition were used for the optimization of agitating speed and cell split interval. Consistent with previous studies (<ce:cross-refs refid="bb0080 bb0110" id="cf0305">Zweigerdt et al., 2011; Singh et al., 2010</ce:cross-refs>), preliminary experiments using seeding density lower than 4<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml showed inconsistent cell survival and proliferation (data not shown). Thus, we used 4<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup> to 5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">5</ce:sup><ce:hsp sp="0.25"/>cells/ml as the seeding density for all following experiments. After treatment with ROCK inhibitor and dissociation, a single cell suspension of BC1 hiPSCs from feeder-free adhesion culture was directly inoculated into the spinner flask with 45<ce:hsp sp="0.25"/>ml of E8<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>Y27632. Cell growth at agitating speeds of 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm, and 75<ce:hsp sp="0.25"/>rpm was compared, and three independent repeats were performed in each condition (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3). Within 24<ce:hsp sp="0.25"/>h, hiPSCs formed spherical aggregates with diameters of 104.2<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>44.8<ce:hsp sp="0.25"/>μm, 80.6<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>20.3<ce:hsp sp="0.25"/>μm, and 60.8<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>16.5<ce:hsp sp="0.25"/>μm on average in 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm and 75<ce:hsp sp="0.25"/>rpm, respectively (<ce:cross-ref refid="f0010" id="cf0310">Fig. 2</ce:cross-ref>d-e). The cell aggregates gradually increased in size along the culture period reaching 120-300<ce:hsp sp="0.25"/>μm on day 5. This is partially due to aggregate agglomeration, but mostly due to the expansion of the cells with 2-3 fold increase after 5-day culture (<ce:cross-ref refid="f0010" id="cf0315">Fig. 2</ce:cross-ref>f-g). These results further demonstrated significantly higher cell density (<ce:cross-ref refid="f0010" id="cf0320">Fig. 2</ce:cross-ref>f, <ce:italic>P</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.0188) without compromising cell viability (<ce:cross-ref refid="f0010" id="cf0325">Fig. 2</ce:cross-ref>g) in hiPSCs cultured in agitation rate of 60<ce:hsp sp="0.25"/>rpm. Moreover, hiPSCs formed more homogeneous aggregates at 60<ce:hsp sp="0.25"/>rpm compared to hiPSCs cultured in 40<ce:hsp sp="0.25"/>rpm and 75<ce:hsp sp="0.25"/>rpm (<ce:cross-ref refid="f0010" id="cf0330">Fig. 2</ce:cross-ref>e and Supplementary Fig. S3a). The cell expansion rate decreased from day 3 to day 4 (<ce:cross-ref refid="f0010" id="cf0335">Fig. 2</ce:cross-ref>f) while the cell viability varied on day 5 (<ce:cross-ref refid="f0010" id="cf0340">Fig. 2</ce:cross-ref>g). Therefore, we decided to culture the cells at 60<ce:hsp sp="0.25"/>rpm and split them every 3 to 4<ce:hsp sp="0.25"/>days.</ce:para></ce:section><ce:section id="s0050" view="all"><ce:section-title id="st0075">Characterization of hiPSCs in dynamic suspension culture</ce:section-title><ce:para id="p0075" view="all">We continued to characterize BC1 cells cultured in the spinner flasks for pluripotency associated marker expression, apoptosis level, and metabolism. We found that &gt;<ce:hsp sp="0.10"/>98% of the cells are positive for TRA-1-60, SSEA4, NANOG, and OCT4 after 4<ce:hsp sp="0.25"/>days of culture by flow cytometry analysis (<ce:cross-ref refid="f0015" id="cf0345">Fig. 3</ce:cross-ref>a<ce:float-anchor refid="f0015"/>). The fluorescent images by confocal microscopy showed the nuclear expression of OCT4 with membrane localization of SSEA4 in BC1 cell aggregates sampled from suspension culture on day 3 (<ce:cross-ref refid="f0015" id="cf0350">Fig. 3</ce:cross-ref>b), indicating the maintenance of the undifferentiated state inside the cell aggregates. We further found that the cell number per aggregate increased in the order of the cubic diameter - the volume (<ce:cross-ref refid="f0015" id="cf0355">Fig. 3</ce:cross-ref>c). Together with the confocal z-stack images of cell aggregates, our data suggested an even distribution of cells throughout the entire aggregate without compact center or hollow cavity. The rate of apoptosis in the cell aggregates was found to be 1.56%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.1% (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3, <ce:cross-ref refid="f0015" id="cf0360">Fig. 3</ce:cross-ref>d), indicating no severe programmed cell death due to the aggregate formation and the dynamic culture. Cell metabolism was monitored by measuring the consumption of glucose, the accumulation of lactate, the change of pH and the oxygen partial pressure (pO<ce:inf loc="post">2</ce:inf>) in the culture medium. We found that by replacing 2/3 of the medium daily with pre-warmed fresh E8, the consumption of glucose did not exceed 40%. Also, the concentration of lactate was restricted under 10<ce:hsp sp="0.25"/>mM (<ce:cross-ref refid="f0015" id="cf0365">Fig. 3</ce:cross-ref>e), and the pH dropped to 6.75 by day 5 (<ce:cross-ref refid="f0015" id="cf0370">Fig. 3</ce:cross-ref>f). For real-time monitoring of pO<ce:inf loc="post">2</ce:inf> in the medium, a non-invasive O<ce:inf loc="post">2</ce:inf> sensor and optical fiber probe were equipped to the bioreactor (<ce:cross-ref refid="bb0190" id="cf0375">Abaci et al., 2012</ce:cross-ref>). We show that the pO<ce:inf loc="post">2</ce:inf> was kept above 15% (<ce:cross-ref refid="f0015" id="cf0380">Fig. 3</ce:cross-ref>g), indicating sufficient oxygen supply merely by diffusion through the gas-liquid interface and convective transport in the medium. These data are consistent with the exponential growth on the first three days followed by a reduced expansion rate after day 4 when the cell density reached ~<ce:hsp sp="0.10"/>1.5<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">6</ce:sup><ce:hsp sp="0.25"/>cells/ml (<ce:cross-ref refid="f0010" id="cf0385">Fig. 2</ce:cross-ref>f).</ce:para></ce:section><ce:section id="s0055" view="all"><ce:section-title id="st0080">Serial passaging and expansion of hiPSCs in suspension culture</ce:section-title><ce:para id="p0085" view="all">To meet the requirement of scale-up processes for hiPSC production, serial passaging and extended expansion of BC1 and TNC1 cells cultured in our bioreactor system were tested. Human iPSCs were inoculated into spinner flasks as mentioned above, cultured for 3 to 4<ce:hsp sp="0.25"/>days, passaged as a single cell suspension, and re-inoculated at the same conditions. Both BC1 and TNC1 cells were maintained in spinner flasks for at least 2.5<ce:hsp sp="0.25"/>months with 25 passages. During the culture period, BC1 showed an average expansion rate of 2.4<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.3 per passage, while TNC1 expanded 3.5<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.5 folds per passage on average (<ce:cross-ref refid="f0020" id="cf0390">Fig. 4</ce:cross-ref>a<ce:float-anchor refid="f0020"/>), indicating variation of growth rate in suspension culture between the two different cell lines. The cells maintained high viability during the serial passaging in suspension. The overall viability was 92.9%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>2.1% for BC1 and 95.0%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>1.6% for TNC1 (<ce:cross-ref refid="f0020" id="cf0395">Fig. 4</ce:cross-ref>b). Both cell lines were also maintained in their undifferentiated state, as indicated by 95-100% positive stain of TRA-1-60, SSEA4, OCT4, and NANOG during the expansion period (<ce:cross-ref refid="f0020" id="cf0400">Fig. 4</ce:cross-ref>c). Furthermore, BC1 and TNC1 cultured for up to 20 passages in spinner flask (plus at least 20 passages in feeder-free adhesion culture before transfer to suspension culture) retained normal karyotypes (<ce:cross-ref refid="f0020" id="cf0405">Fig. 4</ce:cross-ref>d).</ce:para></ce:section><ce:section id="s0060" view="all"><ce:section-title id="st0085">Differentiation potential of hiPSCs in suspension culture</ce:section-title><ce:para id="p0095" view="all">BC1 and TNC1 hiPSCs cultured in spinner flasks for more than 10 passages were tested for their pluripotency by in vitro and in vivo differentiation methods. For in vitro assay, by simply replacing the entire E8 medium with differentiation medium of day-2 spinner flask suspension culture, BC1 and TNC1 aggregates transformed into EBs and started spontaneous differentiation under the stimulation of 10% serum (Supplementary Fig. S4). After 8<ce:hsp sp="0.25"/>days in spinner flask followed by 4<ce:hsp sp="0.25"/>days on gelatin-coated tissue culture plates in differentiation medium, cells of all three germ layers could be detected by immunofluorescent staining of specific markers (<ce:cross-ref refid="f0025" id="cf0410">Fig. 5</ce:cross-ref>a<ce:float-anchor refid="f0025"/>). In contrast, undifferentiated hiPSCs on day 0 showed negative staining of all germ markers (data not shown). For in vivo assay, BC1 and TNC1 harvested from suspension culture in spinner flasks were injected into immune-deficient mice and were able to form teratomas containing cells of all germ layers, including glandular epithelium, chondrocytes, and neural rosettes (<ce:cross-ref refid="f0025" id="cf0415">Fig. 5</ce:cross-ref>b). Directed hematopoietic differentiation potential was also tested as previously described (<ce:cross-ref refid="f0025" id="cf0420">Fig. 5</ce:cross-ref>c). Differentiating BC1 and TNC1 cells contained 43.57%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>4.35% (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) and 43.22%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>7.13% (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) CD34<ce:sup loc="post">+</ce:sup>CD45<ce:sup loc="post">+</ce:sup> HPCs on day 14 of differentiation, respectively. The CFU assay measuring hematopoietic progenitors showed that hiPSCs cultured in spinner flasks were able to generate colonies of different hematopoietic cell lineages. The total number of CFUs was comparable or significantly larger (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.0307, n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) than cells cultured in parallel in adhesion cultures (<ce:cross-ref refid="f0025" id="cf0425">Fig. 5</ce:cross-ref>d).</ce:para></ce:section><ce:section id="s0065" view="all"><ce:section-title id="st0090">Cryopreservation and recovery of hiPSCs in suspension culture</ce:section-title><ce:para id="p0105" view="all">It has been reported that E8 medium with 10% DMSO can be used as cryopreservation medium for hPSCs frozen in small clumps (<ce:cross-ref refid="bb0195" id="cf0430">Beers et al., 2012</ce:cross-ref>). However, whether E8-based freezing medium can support single-cell cryopreservation has not been reported. As the inclusion of Y27632 in freezing medium was proven to enhance single cell survival at thaw (<ce:cross-ref refid="bb0185" id="cf0435">Li et al., 2009</ce:cross-ref>), we examined cryopreservation of hiPSCs harvested from expansion in bioreactors in E8 medium supplemented with 10% (in volume) DMSO and 10<ce:hsp sp="0.25"/>μM Y27632. Following at least two weeks of storage in liquid nitrogen, we thawed the frozen cells in both adhesion and suspension culture conditions. The viability of the frozen cells upon thaw was measured as 89%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>4% for BC1 (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3) and 93%<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>2% for TNC1 (n<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3). Moreover, both BC1 and TNC1 showed good attachment and typical morphology of undifferentiated hiPSCs on Matrigel or VNT-N (<ce:cross-ref refid="f0030" id="cf0440">Fig. 6</ce:cross-ref>a<ce:float-anchor refid="f0030"/>). The cells reached 80% confluence after 3 to 4<ce:hsp sp="0.25"/>days in culture and were passaged routinely hereafter, indicating a rapid recovery and good adaptation back in adhesion culture. Thawed cells were also able to survive and form aggregates in both static and dynamic suspension culture (<ce:cross-ref refid="f0030" id="cf0445">Fig. 6</ce:cross-ref>a). Three protocols for recovery were tested for the purpose of further expansion in suspension. Cells were thawed in adhesion (AD), ultra-low attachment plate (UL), or spinner flask (SF) for the first passage, and then transferred directly to spinner flasks on the next splitting (AD-SF, UL-SF, and SF, respectively, <ce:cross-ref refid="f0030" id="cf0450">Fig. 6</ce:cross-ref>b). We note that the first passage after thawing in static or dynamic suspension culture conditions usually required longer culture period (5 to 6<ce:hsp sp="0.25"/>days) to allow enough cell growth for splitting (<ce:cross-ref refid="f0030" id="cf0455">Fig. 6</ce:cross-ref>b). Cells regained typical expansion rate at the third passage after thawing (<ce:cross-ref refid="f0030" id="cf0460">Fig. 6</ce:cross-ref>b) and contained &gt;<ce:hsp sp="0.10"/>98% of the population with positive staining of TRA-1-60, SSEA4, OCT4, and NANOG after 5 passages (<ce:cross-ref refid="f0030" id="cf0465">Fig. 6</ce:cross-ref>c). Cells in AD-SF and UL-SF conditions showed 2-3-fold higher expansion rate in the first passage than hiPSCs that were directly thawed in spinner flasks (<ce:cross-ref refid="f0030" id="cf0470">Fig. 6</ce:cross-ref>b). The spin-EB hematopoietic differentiation of hiPSCs recovered from UL-SF protocol demonstrated an efficient differentiation into hematopoietic progenitor cells (<ce:cross-ref refid="f0030" id="cf0475">Fig. 6</ce:cross-ref>d). Furthermore, hiPSCs were tested for karyotype stability after sequential freeze-thaw cycles using single-cell cryopreservation. After more than 5 times of sequential freeze-thaw process after adapted to completely xeno-free conditions, including at least 4 times of cryopreservation following UL-SF protocol, both BC1 and TNC1 after ~<ce:hsp sp="0.10"/>70 passages maintained normal karyotype (<ce:cross-ref refid="f0030" id="cf0480">Figs. 6</ce:cross-ref>e and <ce:cross-ref refid="f0020" id="cf0485">4</ce:cross-ref>d), indicating a reliable cryopreservation protocol for hiPSCs throughout their useful lifespan. This xeno-free cryopreservation and recovery protocol completed our bioreactor system, offering opportunities for large-scale cell growth and banking of hiPSC lines.</ce:para></ce:section></ce:section></ce:section><ce:section id="s0015" view="all"><ce:section-title id="st0030">Discussion</ce:section-title><ce:para id="p0110" view="all">Following the demonstration that a ROCK inhibitor such as Y27632 permits the survival of single-cell hESCs (<ce:cross-ref refid="bb0065" id="cf0490">Watanabe et al., 2007</ce:cross-ref>), several groups utilized it to establish suspension culture systems for the expansion of hPSCs based on single-cell inoculation (<ce:cross-refs refid="bb0070 bb0075 bb0080 bb0085 bb0090 bb0095 bb0100 bb0105 bb0110 bb0115" id="cf0495">Amit et al., 2011; Olmer et al., 2010; Zweigerdt et al., 2011; Abbasalizadeh et al., 2012; Chen et al., 2012; Fluri et al., 2012; Krawetz et al., 2010; Olmer et al., 2012; Singh et al., 2010; Steiner et al., 2010</ce:cross-refs>). Zweigerdt et al. and Amit et al. established detailed protocols for the adaptation and suspension culture of hPSCs in a variety of vessel types (<ce:cross-refs refid="bb0070 bb0080" id="cf0500">Amit et al., 2011; Zweigerdt et al., 2011</ce:cross-refs>). Recently, Olmer et al. reported a high yield culture in a monitored spinner flask with 100-ml working volume. Up to 2<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">8</ce:sup> of hiPSCs were obtained in a single run of 7<ce:hsp sp="0.25"/>days (<ce:cross-ref refid="bb0105" id="cf0505">Olmer et al., 2012</ce:cross-ref>). Chen et al. showed long-term culture of hESCs in suspension for at least 20 passages with an average 4.3-fold expansion rate within 3 to 4<ce:hsp sp="0.25"/>days of interval, and demonstrated a complete strategy for hESC banking under cGMP or cGLP condition (<ce:cross-ref refid="bb0090" id="cf0510">Chen et al., 2012</ce:cross-ref>). Most of these approaches were based on serum-free media that contain BSA Fraction V or human serum albumin as the major protein component. The batch-to-batch variance of this animal-source product led to compromised defined medium (<ce:cross-ref refid="bb0040" id="cf0515">Chen et al., 2011</ce:cross-ref>). Toward this, we first transferred hPSCs into the newly developed E8 medium on human vitronectin substrate, to avoid BSA and have a completely xeno-free condition with low concentration of protein components. We then demonstrated that E8 medium (with Y27632 on the first day of seeding) is sufficient to support hiPSC aggregation and survival, and serial passaging in the undifferentiated state using static suspension culture.</ce:para><ce:para id="p0115" view="all">We next aimed to optimize the protocol for dynamic suspension culture in spinner flasks. While there are many experimental and computational studies for assessing the flow dynamics in spinner flasks equipped with various types of paddle-shaped impellers (<ce:cross-refs refid="bb0200 bb0205 bb0210 bb0215 bb0220" id="cf0520">Bilgen and Barabino, 2007; Collignon et al., 2010; Papoutsakis, 1991; Venkat et al., 1996; Youn et al., 2006</ce:cross-refs>), the relevant analysis for glass-ball spinner flasks has not been reported. We simulated the velocity field and shear stress of the flow in the glass-ball type spinner flask, providing reasonable prediction of the effect of flow on single cells during the first several hours after inoculation. Some rational approximations were applied to simplify the model, such as using the properties of 37<ce:hsp sp="0.25"/>°C water instead of the unknown data of the medium, omitting gravity due to its negligible effects on single cells compared to the agitating force, and ignoring the cell aggregation due to the complexity it would bring to the model. Although the model could not estimate the shear stress on the surface of cell aggregates after emergence, the method provides an efficient tool for the design and analysis of the bioreactors with complex vessel structures or non-standardized impeller designs (<ce:cross-refs refid="bb0200 bb0215" id="cf0525">Bilgen and Barabino, 2007; Venkat et al., 1996</ce:cross-refs>). Using CFD analysis, we found a steady flow in all agitation speeds (i.e. 40<ce:hsp sp="0.25"/>rpm, 60<ce:hsp sp="0.25"/>rpm and 75<ce:hsp sp="0.25"/>rpm). Although small turbulent flow may occur at high agitating speeds according to the calculation of the local Reynolds number, the shear stress generated by the glass-ball impeller is considerably lower than by other types of impellers. Experimentally, we further found that an agitation speed of 60<ce:hsp sp="0.25"/>rpm supports the formation of homogeneous cell aggregates, showing significantly higher expansion rates and relatively better cell viability than the other agitation speeds. As a comparison, hiPSCs formed relatively large aggregates on day 1 at 40<ce:hsp sp="0.25"/>rpm, which reduced the potential of further proliferation due to the diffusion limitation. Moreover, occasions of undesired aggregate agglomeration, resulting in aggregates larger than 800<ce:hsp sp="0.25"/>μm, were observed on later days due to insufficient agitating force (from Supplementary Fig. S3b). At 75<ce:hsp sp="0.25"/>rpm, cell viability dropped significantly on day 1, leading to slower recovery and expansion. Based on these results, the optimal split interval at 60<ce:hsp sp="0.25"/>rpm was next determined. We noticed a reduction in cell expansion after day 3 or day 4, which might be due to the diffusion limitation as cell aggregates grow. It is widely accepted that the diffusion limitation of oxygen in human tissue is 100 to 200<ce:hsp sp="0.25"/>μm (<ce:cross-ref refid="bb0225" id="cf0530">Hoeben et al., 2004</ce:cross-ref>). Therefore, we determined to split the cells on day 3 or day 4 when most of the cell aggregate diameters reached ~<ce:hsp sp="0.10"/>150-200<ce:hsp sp="0.25"/>μm. The concentration of glucose and lactate in the culture media also suggested a reduced growth after day 3, when the pH of the media drop to ~<ce:hsp sp="0.10"/>6.75 as cell density increased, which might be harmful for the hiPSC lines that are more sensitive to changes in pH and influence the expansion. This issue may be solved by gradually increasing the culture volume or the media change frequency. The inclusion of a non-invasive O<ce:inf loc="post">2</ce:inf> probe-patch made it possible to monitor pO<ce:inf loc="post">2</ce:inf> levels real-time without disturbing the flow and the rotation of the impeller in the glass-ball bioreactor, which are normally difficult to equip with a standard large O<ce:inf loc="post">2</ce:inf> probe (<ce:cross-refs refid="bb0080 bb0230" id="cf0535">Zweigerdt et al., 2011; Niebruegge et al., 2009</ce:cross-refs>).</ce:para><ce:para id="p0120" view="all">Using the optimized operating conditions we demonstrate serial passaging and expansion of two integration-free hiPSC lines in completely defined xeno-free media in 100-ml bioreactors. The cells exhibited homogeneous aggregate formation, steady expansion in their pluripotent state, and normal karyotype after ~<ce:hsp sp="0.10"/>20 passages. Note that one experiment of extended expansion of TNC1 cells in spinner flask (p30<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>6<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>21) showed abnormal karyotype (47, XXY). However, there is no evidence that it should be attributed to the suspension culture. In general, recently improved iPSC culture conditions reduce selective pressure for the growth of mutated cells that acquire growth advantages. Although karyotypically abnormal cells were found occasionally after long-term cultures under both adherent and suspension conditions, the frequency is low (5% of tested batches of hiPSCs and hESCs). The standard karyotyping or other genotyping methods like what we performed here will remain necessary to manage this inherent issue of long-term cell cultures.</ce:para><ce:para id="p0125" view="all">Undifferentiated hiPSCs expanded in bioreactors retained their potential of spontaneous and directed hematopoietic differentiation comparable to cells cultured via adherent culture. The transformation from day 2 or day 3 cell aggregates to EBs for spontaneous differentiation in the spinner flask demonstrates the possibility to use this system for a continuous bioprocess that begins with a large-scale expansion and directed differentiation in one single batch. Interestingly, although comparable amount of HPCs and CFU was derived from hiPSCs expanded in bioreactor as in adhesion, HPCs derived from TNC1 in bioreactor generated a considerably higher proportion of cells in erythroid lineage rather than in myelocyte lineage. Further studies are needed to reveal the significance and the mechanism underlying the contribution of hydrodynamic forces to hPSC differentiation in suspension. Studies of hematopoietic differentiation in spinner flasks are ongoing.</ce:para><ce:para id="p0130" view="all">The development of a single-cell cryopreservation protocol concluded the establishment of our chemically defined xeno-free suspension culture system. For continuous expansion, UL-SF protocol was the preferred method for recovery with small number of hiPSCs from cryopreservation. The hiPSCs can be directly thawed in a spinner flask; cells cultured in a spinner flask can be transferred back to VNT-N-coated surface for the applications that require adhesion culture, indicating good flexibility of the system. The single-cell cryopreservation protocol and the suspension culture system can significantly reduce the workload when handling cells in the scale required for translational uses. Furthermore, this xeno-free protocol of cryopreservation and recovery was theoretically proved to be compliant to a scale-up strategy for hiPSCs in suspension and under cGMP condition, allowing a yield of ~<ce:hsp sp="0.10"/>1<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">9</ce:sup> cells within 20<ce:hsp sp="0.25"/>days after thawing of 1<ce:hsp sp="0.25"/>×<ce:hsp sp="0.25"/>10<ce:sup loc="post">6</ce:sup> frozen cells (<ce:cross-ref refid="f0035" id="cf0540">Fig. 7</ce:cross-ref><ce:float-anchor refid="f0035"/>). The scale-up strategy, which includes multiple xeno-free processes, employs 100-ml and 1-l spinner flasks, enabling the transition from lab scale to pilot scale of hiPSC expansion. The CFD simulation of the 1-l spinner flask (Supplementary Fig. S5) equipped with two glass-ball stirring pendulums (such as one from Integra Bio-sciences) indicated that it could be scalable using 1-l spinner flasks toward clinically relevant quantities of hiPSCs from a single batch. The simulation revealed a steady flow at the highest agitating speed of 75<ce:hsp sp="0.25"/>rpm and an even lower maximum shear stress (0.047<ce:hsp sp="0.25"/>N/m<ce:sup loc="post">2</ce:sup>) compared to the 100-ml spinner flask in steady state. On one hand, the distance between the farthest points of the pendulums and the spin axis (<ce:italic>r</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>38.9<ce:hsp sp="0.25"/>mm in Supplementary Fig. S5, equivalent to impeller radius of paddle impellers) in the 1-l spinner flask is not much longer than the 100-ml spinner flask (<ce:italic>r</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>28.2<ce:hsp sp="0.25"/>mm); thus, the highest velocity in 1-l spinner flasks is not much higher than that in 100-ml spinner flasks (<ce:italic>v</ce:italic><ce:inf loc="post">max,1<ce:hsp sp="0.25"/>l</ce:inf><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.309<ce:hsp sp="0.25"/>m/s vs. <ce:italic>v</ce:italic><ce:inf loc="post">max,100<ce:hsp sp="0.25"/>ml</ce:inf><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.224<ce:hsp sp="0.25"/>m/s). On the other hand, there is much more space between the pendulums to the flask wall in the radial direction (<ce:italic>l</ce:italic> in Supplementary Fig. S5, <ce:italic>l</ce:italic><ce:inf loc="post">1<ce:hsp sp="0.25"/>l</ce:inf><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>29.1<ce:hsp sp="0.25"/>mm vs. <ce:italic>l</ce:italic><ce:inf loc="post">100<ce:hsp sp="0.25"/>ml</ce:inf><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>3.5<ce:hsp sp="0.25"/>mm). This causes a more moderate drop of velocity from the maximum at the far reach of the pendulums to zero at the flask wall in 1-l spinner flask compared to the 100-ml spinner flask, leading to a significant decrease of the gradient of velocity, d<ce:italic>v<ce:inf loc="post">z</ce:inf></ce:italic>/d<ce:italic>x</ce:italic>, which contributes to the majority of the shear stress. Before reaching steady state, stepping acceleration could be used to protect the cells from sudden exposure to high-speed flow. Also, the liquid level of 600-ml medium in the 1-l spinner flask is similar to that of 60-ml medium in the 100-ml spinner flask, which was proven in this study not to cause any reduced O<ce:inf loc="post">2</ce:inf> transport (from <ce:cross-ref refid="f0015" id="cf0545">Fig. 3</ce:cross-ref>g). While optimization of the agitation speed should be performed for different hiPSC lines to support appropriate size aggregate formation (for example, diameter of 50-80<ce:hsp sp="0.25"/>μm after 24<ce:hsp sp="0.25"/>h), this direct scale-up process in 1-l spinner flasks with the same well-designed system should be attainable.</ce:para><ce:para id="p0135" view="all">Another practical advantage of the system is its relative low cost. The high price of current commercially available serum-free media such as StemPro and mTeSR always hinders the universal application of the scale-up technologies for hiPSC expansion, especially for xeno-free media when albumin is required in the medium (<ce:cross-ref refid="bb0040" id="cf0550">Chen et al., 2011</ce:cross-ref>). The simplicity of the medium dramatically cuts down the price (~<ce:hsp sp="0.10"/>30%-60%) and makes it possible for bulk production in academic laboratories and cGMP-compliant institutions.</ce:para><ce:para id="p0140" view="all">In conclusion, we established a reproducible approach for rapid, economic, and scalable expansion of hiPSCs in xeno-free condition to meet the demand of practical research and clinical applications. The complete elimination of components from animal sources and remarkably reduced cost of this system provide a reliable technology for scale-up of hiPSC expansion and take a significant step toward the realization of stem cell therapies.</ce:para></ce:section><ce:section id="s0135" view="all"><ce:section-title id="st0160">Author contributions</ce:section-title><ce:para id="p0155" view="all">Y.W., S.G. and L.C. developed the concepts and designed the experiments; Y.W., B.C., C.H. and S.D. performed the experiments; Y.W., S.G. and L.C. analyzed the results and wrote the paper.</ce:para></ce:section><ce:section id="s0140" view="all"><ce:section-title id="st0165">Competing financial interests</ce:section-title><ce:para id="p0300" view="all">The authors declare no competing financial interests.</ce:para></ce:section></ce:sections><ce:acknowledgment id="ac0005" view="all"><ce:section-title id="st0035">Acknowledgment</ce:section-title><ce:para id="p0145" view="all">We thank members in the laboratories of Drs. Gerecht and Cheng for discussions and support. We thank Sravanti Kusuma for helping with edits of this manuscript. This study is supported in part by <ce:grant-sponsor id="gts0005" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Edythe Harris Lucas and Clara Lucas Lynn Chair in Hematology</ce:grant-sponsor> to L.C., and grants from <ce:grant-sponsor id="gts0010" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Maryland Stem Cell Research Fund</ce:grant-sponsor> (<ce:grant-number refid="gts0010">2011-MSCRFII-0088</ce:grant-number> to L.C.), <ce:grant-sponsor id="gts0015" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">NIH</ce:grant-sponsor> (<ce:grant-number refid="gts0015">U01-HL107446</ce:grant-number> and <ce:grant-number refid="gts0015">2R01-HL073781</ce:grant-number> to L.C.) and <ce:grant-sponsor id="gts0020" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">NSF</ce:grant-sponsor> (<ce:grant-number refid="gts0020">1054415</ce:grant-number> to S.G.).</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="s0145" view="extended"><ce:label>Appendix A</ce:label><ce:section-title id="st0170">Supplementary data</ce:section-title><ce:para id="p0330" view="all"><ce:display><ce:e-component id="ec0005"><ce:caption id="ca0040"><ce:simple-para id="sp0050" view="all">Supplementary figures and methods.</ce:simple-para></ce:caption><ce:link locator="mmc1"/></ce:e-component></ce:display></ce:para></ce:section><ce:section view="compact-standard" id="s0150"><ce:label>Appendix A</ce:label><ce:section-title id="st0175">Supplementary data</ce:section-title><ce:para id="p0335" view="all">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="doi:10.1016/j.scr.2013.07.011" id="ir0005" xlink:type="simple">http://dx.doi.org/10.1016/j.scr.2013.07.011</ce:inter-ref>.</ce:para></ce:section></ce:appendices></body><tail view="all"><ce:bibliography id="bi0005" view="all"><ce:section-title id="st0045">References</ce:section-title><ce:bibliography-sec id="bs0005" view="all"><ce:bib-reference id="bb0190"><ce:label>Abaci et al., 2012</ce:label><sb:reference id="rf0190"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.E.</ce:given-name><ce:surname>Abaci</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Microbioreactors to manipulate oxygen tension and shear stress in the microenvironment of vascular stem and progenitor cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Appl. Biochem.</sb:maintitle></sb:title><sb:volume-nr>59</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>97</sb:first-page><sb:last-page>105</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0085"><ce:label>Abbasalizadeh et al., 2012</ce:label><sb:reference id="rf0085"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Abbasalizadeh</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tissue Eng. Part C Methods</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:issue-nr>11</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>831</sb:first-page><sb:last-page>851</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0155"><ce:label>Adamo et al., 2009</ce:label><sb:reference id="rf0155"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Adamo</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Biomechanical forces promote embryonic haematopoiesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>459</sb:volume-nr></sb:series><sb:issue-nr>7250</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1131-U120</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0070"><ce:label>Amit et al., 2011</ce:label><sb:reference id="rf0070"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Amit</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>572</sb:first-page><sb:last-page>579</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0195"><ce:label>Beers et al., 2012</ce:label><sb:reference id="rf0195"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Beers</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:issue-nr>11</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>2029</sb:first-page><sb:last-page>2040</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0120"><ce:label>Bigdeli et al., 2008</ce:label><sb:reference id="rf0120"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Bigdeli</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>133</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>146</sb:first-page><sb:last-page>153</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0200"><ce:label>Bilgen and Barabino, 2007</ce:label><sb:reference id="rf0200"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Bilgen</ce:surname></sb:author><sb:author><ce:given-name>G.A.</ce:given-name><ce:surname>Barabino</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Location of scaffolds in bioreactors modulates the hydrodynamic environment experienced by engineered tissues</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Bioeng.</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>282</sb:first-page><sb:last-page>294</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0040"><ce:label>Chen et al., 2011</ce:label><sb:reference id="rf0040"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.K.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Chemically defined conditions for human iPSC derivation and culture</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Methods</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>424-U76</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0090"><ce:label>Chen et al., 2012</ce:label><sb:reference id="rf0090"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.C.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Scalable GMP compliant suspension culture system for human ES cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cell Res.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>388</sb:first-page><sb:last-page>402</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0005"><ce:label>Chou et al., 2011</ce:label><sb:reference id="rf0005"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.K.</ce:given-name><ce:surname>Chou</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Res</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>518</sb:first-page><sb:last-page>529</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0205"><ce:label>Collignon et al., 2010</ce:label><sb:reference id="rf0205"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Collignon</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Axial impeller selection for anchorage dependent animal cell culture in stirred bioreactors: methodology based on the impeller comparison at just-suspended speed of rotation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Chem. Eng. Sci.</sb:maintitle></sb:title><sb:volume-nr>65</sb:volume-nr></sb:series><sb:issue-nr>22</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>5929</sb:first-page><sb:last-page>5941</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0180"><ce:label>Cormier et al., 2006</ce:label><sb:reference id="rf0180"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.T.</ce:given-name><ce:surname>Cormier</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tissue Eng.</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:issue-nr>11</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>3233</sb:first-page><sb:last-page>3245</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0125"><ce:label>Desbordes and Studer, 2013</ce:label><sb:reference id="rf0125"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Desbordes</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adapting human pluripotent stem cells to high-throughput and high-content screening</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>111</sb:first-page><sb:last-page>130</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0010"><ce:label>Dowey et al., 2012</ce:label><sb:reference id="rf0010"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.N.</ce:given-name><ce:surname>Dowey</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:issue-nr>11</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>2013</sb:first-page><sb:last-page>2021</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0095"><ce:label>Fluri et al., 2012</ce:label><sb:reference id="rf0095"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Fluri</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Methods</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>509</sb:first-page><sb:last-page>516</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0225"><ce:label>Hoeben et al., 2004</ce:label><sb:reference id="rf0225"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Hoeben</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Vascular endothelial growth factor and angiogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pharmacol. Rev.</sb:maintitle></sb:title><sb:volume-nr>56</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>549</sb:first-page><sb:last-page>580</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0025"><ce:label>Kehoe et al., 2010</ce:label><sb:reference id="rf0025"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Kehoe</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Scalable stirred-suspension bioreactor culture of human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tissue Eng. Part A</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>405</sb:first-page><sb:last-page>421</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0100"><ce:label>Krawetz et al., 2010</ce:label><sb:reference id="rf0100"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Krawetz</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tissue Eng. Part C Methods</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>573</sb:first-page><sb:last-page>582</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0045"><ce:label>Li et al., 2005</ce:label><sb:reference id="rf0045"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Bioeng.</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>688</sb:first-page><sb:last-page>698</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0185"><ce:label>Li et al., 2009</ce:label><sb:reference id="rf0185"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>ROCK inhibitor improves survival of cryopreserved serum/feeder-free single human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum. Reprod.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>580</sb:first-page><sb:last-page>589</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0050"><ce:label>Ludwig et al., 2006</ce:label><sb:reference id="rf0050"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.E.</ce:given-name><ce:surname>Ludwig</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Derivation of human embryonic stem cells in defined conditions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>185</sb:first-page><sb:last-page>187</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0020"><ce:label>Mehta et al., 2009</ce:label><sb:reference id="rf0020"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mehta</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Optimizing the CD34<ce:hsp sp="0.10"/>+ cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Leuk. Lymphoma</sb:maintitle></sb:title><sb:volume-nr>50</sb:volume-nr></sb:series><sb:issue-nr>9</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1434</sb:first-page><sb:last-page>1441</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0140"><ce:label>Ng et al., 2005</ce:label><sb:reference id="rf0140"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.S.</ce:given-name><ce:surname>Ng</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Blood</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1601</sb:first-page><sb:last-page>1603</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0135"><ce:label>Ng et al., 2008</ce:label><sb:reference id="rf0135"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.S.</ce:given-name><ce:surname>Ng</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>768</sb:first-page><sb:last-page>776</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0230"><ce:label>Niebruegge et al., 2009</ce:label><sb:reference id="rf0230"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Niebruegge</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Bioeng.</sb:maintitle></sb:title><sb:volume-nr>102</sb:volume-nr></sb:series><sb:issue-nr>2</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>493</sb:first-page><sb:last-page>507</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0170"><ce:label>O'Connor and Terry Papoutsakis, 1992</ce:label><sb:reference id="rf0170"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.C.</ce:given-name><ce:surname>O'Connor</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Terry Papoutsakis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Agitation effects on microcarrier and suspension CHO cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Tech.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>323</sb:first-page><sb:last-page>328</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0030"><ce:label>Okita et al., 2007</ce:label><sb:reference id="rf0030"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Okita</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ichisaka</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamanaka</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of germline-competent induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>448</sb:volume-nr></sb:series><sb:issue-nr>7151</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>313-U1</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0075"><ce:label>Olmer et al., 2010</ce:label><sb:reference id="rf0075"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Olmer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cell Res.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>51</sb:first-page><sb:last-page>64</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0105"><ce:label>Olmer et al., 2012</ce:label><sb:reference id="rf0105"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Olmer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Tissue Eng. Part C Methods</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:issue-nr>10</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>772</sb:first-page><sb:last-page>784</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0210"><ce:label>Papoutsakis, 1991</ce:label><sb:reference id="rf0210"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.T.</ce:given-name><ce:surname>Papoutsakis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Fluid-mechanical damage of animal cells in bioreactors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:issue-nr>12</sb:issue-nr><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>427</sb:first-page><sb:last-page>437</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0110"><ce:label>Singh et al., 2010</ce:label><sb:reference id="rf0110"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Singh</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Up-scaling single cell-inoculated suspension culture of human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cell Res.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>165</sb:first-page><sb:last-page>179</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0115"><ce:label>Steiner et al., 2010</ce:label><sb:reference id="rf0115"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Steiner</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>361</sb:first-page><sb:last-page>364</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0130"><ce:label>Stover and Schwartz, 2011</ce:label><sb:reference id="rf0130"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.E.</ce:given-name><ce:surname>Stover</ce:surname></sb:author><sb:author><ce:given-name>P.H.</ce:given-name><ce:surname>Schwartz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Methods Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>767</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>137</sb:first-page><sb:last-page>146</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0175"><ce:label>Sucosky et al., 2004</ce:label><sb:reference id="rf0175"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Sucosky</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Fluid mechanics of a spinner-flask bioreactor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Bioeng.</sb:maintitle></sb:title><sb:volume-nr>85</sb:volume-nr></sb:series><sb:issue-nr>1</sb:issue-nr><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>34</sb:first-page><sb:last-page>46</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0055"><ce:label>Vallier et al., 2005</ce:label><sb:reference id="rf0055"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Vallier</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Alexander</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Pedersen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Activin/nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Sci.</sb:maintitle></sb:title><sb:volume-nr>118</sb:volume-nr></sb:series><sb:issue-nr>Pt 19</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>4495</sb:first-page><sb:last-page>4509</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0215"><ce:label>Venkat et al., 1996</ce:label><sb:reference id="rf0215"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.V.</ce:given-name><ce:surname>Venkat</ce:surname></sb:author><sb:author><ce:given-name>L.R.</ce:given-name><ce:surname>Stock</ce:surname></sb:author><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Chalmers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Study of hydrodynamics in microcarrier culture spinner vessels: a particle tracking velocimetry approach</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Bioeng.</sb:maintitle></sb:title><sb:volume-nr>49</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>456</sb:first-page><sb:last-page>466</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0060"><ce:label>Wang et al., 2007</ce:label><sb:reference id="rf0060"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Blood</sb:maintitle></sb:title><sb:volume-nr>110</sb:volume-nr></sb:series><sb:issue-nr>12</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>4111</sb:first-page><sb:last-page>4119</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0065"><ce:label>Watanabe et al., 2007</ce:label><sb:reference id="rf0065"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Watanabe</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A ROCK inhibitor permits survival of dissociated human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>681</sb:first-page><sb:last-page>686</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0160"><ce:label>Yamamoto et al., 2005</ce:label><sb:reference id="rf0160"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Yamamoto</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Heart Circ. Physiol.</sb:maintitle></sb:title><sb:volume-nr>288</sb:volume-nr></sb:series><sb:issue-nr>4</sb:issue-nr><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>H1915</sb:first-page><sb:last-page>H1924</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0015"><ce:label>Ye et al., 2009</ce:label><sb:reference id="rf0015"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Ye</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Blood</sb:maintitle></sb:title><sb:volume-nr>114</sb:volume-nr></sb:series><sb:issue-nr>27</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>5473</sb:first-page><sb:last-page>5480</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0165"><ce:label>Yirme et al., 2008</ce:label><sb:reference id="rf0165"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Yirme</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells Dev.</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1227</sb:first-page><sb:last-page>1241</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0220"><ce:label>Youn et al., 2006</ce:label><sb:reference id="rf0220"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.S.</ce:given-name><ce:surname>Youn</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biotechnol. Prog.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:issue-nr>3</sb:issue-nr><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>801</sb:first-page><sb:last-page>810</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0035"><ce:label>Yu et al., 2007</ce:label><sb:reference id="rf0035"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.Y.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Induced pluripotent stem cell lines derived from human somatic cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>318</sb:volume-nr></sb:series><sb:issue-nr>5858</sb:issue-nr><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1917</sb:first-page><sb:last-page>1920</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0145"><ce:label>Yu et al., 2008</ce:label><sb:reference id="rf0145"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Yu</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>461</sb:first-page><sb:last-page>471</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0150"><ce:label>Zhan et al., 2004</ce:label><sb:reference id="rf0150"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Zhan</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>364</sb:volume-nr></sb:series><sb:issue-nr>9429</sb:issue-nr><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>163</sb:first-page><sb:last-page>171</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bb0080"><ce:label>Zweigerdt et al., 2011</ce:label><sb:reference id="rf0080"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Zweigerdt</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Scalable expansion of human pluripotent stem cells in suspension culture</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Protoc.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:issue-nr>5</sb:issue-nr><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>689</sb:first-page><sb:last-page>700</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc>
